Now approved
for the treatment of thrombocytopenia in adult patients with chronic ITP who have had an insufficient response to a previous treatment.

 

Immune Thrombocytopenia (ITP)

DOPTELET® (avatrombopag) is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.

Proceed to website

Chronic Liver Disease (CLD)

DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

Proceed to website